Divi's Laboratories Ltd. (DIVISLAB)
NSE
Closed
Sep 8, 2026
Day's Range
9,253.0052 wk Range
5,636.50Overview - DIVISLAB - Divi's Laboratories Ltd.
Key Statistics
Valuation
Enterprise Value
2.37T
P/E (Trailing)
‪95.30‬
P/E (Forward)
‪61.39‬
PEG Ratio
‪3.46‬
Price / Sales (TTM)
‪21.84‬
Price / Book
‪14.63‬
EV / EBITDA
‪59.83‬
Profitability
Gross Margin
‪60.47%‬
Profit Margin
‪26.04%‬
Operating Margin
‪36.65%‬
Return on Assets
‪12.81%‬
Return on Equity
‪15.32%‬
Ownership
Shares Outstanding
265.46M
Float
117.26M
Held by Insiders
‪51.99%‬
Held by Institutions
‪30.23%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪7,624.62‬
200-Day Avg
‪6,678.00‬
Dividends
Payout Ratio
‪31.01%‬
Frequency
Annual
Analyst Consensus
29 analysts
Average price target
‪₹ 8,292.48‬Market Cap - DIVISLAB - Divi's Laboratories Ltd.
Peers - DIVISLAB - Divi's Laboratories Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
Profile Summary - DIVISLAB - Divi's Laboratories Ltd.
About
Divi's Laboratories Ltd. is an Indian pharmaceutical manufacturing company headquartered in Hyderabad, India, founded in 1990. It specializes in the production of active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients for global innovator and generic drug companies. Divi's Laboratories…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
